CoviVac

CoviVac

Vaccine description
Target disease	COVID-19
Type	Killed/Inactivated
Clinical data
Routes of administration	Intramuscular
Legal status
Legal status	Registered in Russia on 20 February 2021
Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

Part of a series on the
COVID-19 pandemic
SARS-CoV-2 (virus) COVID-19 (disease)
Timeline 2019 December 2020 January February responses March responses April responses May responses June responses
Locations By continent Africa Antarctica Asia Europe North America Oceania South America By conveyance Cruise ships Naval ships Cases Deaths
International response National responses European Union response Protests U.S. Lockdowns Evacuations Travel restrictions
Medical response Disease testing Vaccine research Drug development Drug repurposing
Impact Socio-economic Crime Domestic violence Economic U.S. India recession Environment Financial markets Hospitals Long-term care Misinformation Military Other health issues Politics Pregnancy Prisons Religion Science and technology Social Strikes U.S. abortions Xenophobia and racism Notable deaths By industry Arts and culture Aviation Cannabis Cinema Education Event cancellations Fashion Food Canada meat U.S. meat Journalism Music Performing arts Sports Television U.S. Tourism Video games

CoviVac (Russian: КовиВак, tr. KobiBak) is a COVID-19 vaccine developed by the Chumakov Centre at the Russian Academy of Sciences.

External links

This article "CoviVac" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:CoviVac. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

📰 Article(s) of the same category(ies)

• Muslim Heretics Conference
• William Barker (Nottingham cricketer)
• Hunter (2025 film)
• Gvt.BHS Kanniakulangara
• Erin Clachers
• Ahammed Khabeer
• Steve Judd

---